Journal article
Randomized controlled trial evaluating the clinical benefit of montelukast for treating spring seasonal allergic rhinitis
Abstract
BACKGROUND: Symptoms of allergic rhinitis are mediated in part by cysteinyl leukotrienes.
OBJECTIVE: To evaluate the clinical benefit of montelukast, a cysteinyl leukotriene receptor antagonist, administered once daily for treating seasonal allergic rhinitis.
Authors
van Adelsberg J; Philip G; LaForce CF; Weinstein SF; Menten J; Malice M-P; Reiss TF; Group TMSRI
Journal
Annals of Allergy Asthma & Immunology, Vol. 90, No. 2, pp. 214–222
Publisher
Elsevier
Publication Date
February 2003
DOI
10.1016/s1081-1206(10)62144-8
ISSN
1081-1206